Management of high-risk and post-operative non-metastatic prostate cancer in Catalonia: an expert Delphi consensus

• Marta Bonet ^[1] ; David González ^[1] ; José-Enrique Baquedano ^[1] ; Elena García ^[1] ; Manuel Altabas ^[6] ; Francesc Casas ^[7] ; Nicolás Feltes ^[2] ; Ferran Ferrer ^[3] ; Palmira Foro ^[4] ; Rafael Fuentes ^[8] ; Manuel Galdeano ^[9] ; David Gomez ^[10] ; Ivan Henriquez ^[10] ; Josep Jové ^[11] ; Joan Lozano ^[2] ; Xavier Maldonado ^[6] ; Joel Mases ^[7] ; Ismael Membrive ^[4] ; Saturio Paredes ^[9] ; Àlvar Roselló ^[8] ; Gemma Sancho ^[5] ; Moisés Mira ^[1]
  1. [1] Hospital Universitario Arnau de Vilanova

     Hospital Universitario Arnau de Vilanova

     Lérida, España

     
  2. [2] Hospital de Terrassa

     Hospital de Terrassa

     Barcelona, España

     
  3. [3] Hospital Duran i Reynals

     Hospital Duran i Reynals

     Barcelona, España

     
  4. [4] Parc de Salut MAR

     Parc de Salut MAR

     Barcelona, España

     
  5. [5] Hospital de la Santa Creu i Sant Pau

     Hospital de la Santa Creu i Sant Pau

     Barcelona, España

     
  6. [6] Oncología Radioterápica, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, España
  7. [7] Oncología Radioterápica, Hospital Clínic, ICMHO (Institut Clínic de Malalties Hematològiques i Oncològiques), Barcelona, España
  8. [8] Oncología Radioterápica, Institut Català d'Oncologia, Hospital Josep Trueta, Barcelona, España
  9. [9] Oncología Radioterápica, Consorci Sanitari de Terrassa, Fundació Althaia, Manresa, España
  10. [10] Oncología Radioterápica, Hospital Sant Joan de Reus, Reus, Tarragona, España
  11. [11] Oncología Radioterápica, Institut Català d’Oncologia, Hospital Can Ruti, Badalona, España

  Mostrar afiliaciones +
• Localización: Clinical & translational oncology, ISSN 1699-048X, Vol. 25, Nº. 4 (April), 2023, págs. 1017-1023
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Background To reach a consensus on recommendations for the management of high-risk and post-operative non-metastatic prostate cancer by a group of Radiation Oncologists in Catalonia dedicated to prostate cancer.

    Methods A modified Delphi approach was employed to reach consensus on controversial topics in Radiation Oncology on high-risk non-metastatic (eight questions) and post-operative (eight questions) prostate cancer. An agreement of at least 75% was considered as consensus. The survey was electronically sent 6 weeks before an expert meeting where topics were reviewed and discussed. A second-round survey for the controversial questions only was sent and answered by participants after the meeting.

    Results After the first round of the survey, 19 experienced Radiation Oncologists attended the meeting and 74% fulfilled the second-round online questionnaire. An agreement of 9 of the 16 questions was accounted for the first round. After the meeting, an additional agreement was reached in 3 questions leading to a final consensus on 12 of the 16 questions. There are still controversial topics like the use of PET for staging of high-risk and post-operative non-metastatic prostate cancer and the optimal dose to the prostate bed in the salvage setting.

    Conclusion This consensus contributes to establish recommendations and a framework to help in prostate cancer radiation therapy and pharmacological management in daily clinical practice of high-risk and post-operative non-metastatic prostate cancer.